7 results on '"Polo, G."'
Search Results
2. Tuberculosis of the Hip
- Author
-
Coradin Cc and De Velasco Polo G
- Subjects
Suction (medicine) ,End results ,medicine.medical_specialty ,Irrigation ,Tuberculosis ,business.industry ,General Medicine ,medicine.disease ,Surgery ,Regimen ,Streptomycin ,Medicine ,Orthopedics and Sports Medicine ,Range of motion ,business ,medicine.drug - Abstract
In 51 children with tuberculosis of the hip, overall end results were better, and the range of motion was improved when irrigation-suction with Streptomycin was included in the regimen of surgical management.
- Published
- 1975
3. Experimental study of synadelpho-ureterostomy (transuretero-ureterostomy)
- Author
-
Polo G, Torronteras Jm, and Páramo Pg
- Subjects
medicine.medical_specialty ,Pyelonephritis ,business.industry ,Urology ,medicine.medical_treatment ,Periureteritis ,Hydronephrosis ,Anastomosis ,Peritonitis ,Urinary Diversion ,Transplantation, Autologous ,Surgery ,Ureterostomy ,Ureteral dilatation ,Ureter ,medicine.anatomical_structure ,Dogs ,Postoperative Complications ,Suture (anatomy) ,Urinary Tract Infections ,medicine ,Animals ,business - Abstract
An experimental study with synadelpho-ureterostomy (transuretero-ureterostomy) was performed in 25 dogs. The conclusions reached are: (1) side-to-side anastomosis is to be preferred to end-to-side suture; (2) risk of disruption is very slight even where an unexpected obstruction is encountered (test with induced cellophanic periureteritis), and (3) segmental replacement of the lumbo-iliac ureter may apparently be achieved by means of inverted synadelpho-ureterostomy (the damaged ureter is the recipient ureter). This replacement requires a double synadelphostomy, but in our study the normal transposed ureter suffered no harm despite the presence of previous infection and ureteral dilatation.
- Published
- 1976
4. Nail in the Head
- Author
-
De Velasco Polo G
- Subjects
Male ,Orthodontics ,business.industry ,General Medicine ,medicine.anatomical_structure ,Nail (anatomy) ,medicine ,Humans ,Head (vessel) ,Female ,Orthopedics and Sports Medicine ,Surgery ,business ,Wit and Humor as Topic - Published
- 1974
5. Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
- Author
-
Maria Angela Losi, Riccardo Alessandro, Maurizio Postorino, Federico Pieruzzi, Paolo Colomba, Sandro Feriozzi, Yuri Battaglia, Andrea Frustaci, Alessandra Testa, Ines Monte, Daniele Masarone, Serafina Sciarrino, Antonello Giordano, Antonio Pisani, Cinzia Castana, Carmine Zoccali, Elisabetta Zachara, Giuseppe Limongelli, Eleonora Riccio, Luisa Amico, Claudio Ferri, Alessandro P. Burlina, Renzo Mignani, Margherita Stefania Rodolico, Rosa Napoletano, Marina Caserta, Carmela Zizzo, Simone Scalia, Marco Spada, Roberta Oliveri, Giuseppe Cammarata, Marco Lombardi, Cristina Chimenti, Daniele Francofonte, Giovanni Duro, Maurizio Tenuta, Giuseppe Palladino, Alberto Burlina, Camillo Autore, Giulia Polo, Maurizio Pieroni, Duro, G., Zizzo, C., Cammarata, G., Burlina, A., Polo, G., Scalia, S., Oliveri, R., Sciarrino, S., Francofonte, D., Alessandro, R., Pisani, A., Palladino, G., Napoletano, R., Tenuta, M., Masarone, D., Limongelli, G., Riccio, E., Frustaci, A., Chimenti, C., Ferri, C., Pieruzzi, F., Pieroni, M., Spada, M., Castana, C., Caserta, M., Monte, I., Rodolico, M. S., Feriozzi, S., Battaglia, Y., Amico, L., Losi, M. A., Autore, C., Lombardi, M., Zoccali, C., Testa, A., Postorino, M., Mignani, R., Zachara, E., Giordano, A., Colomba, P., Duro G., Zizzo C., Cammarata G., Burlina A., Polo G., Scalia S., Oliveri R., Sciarrino S., Francofonte D., Alessandro R., Pisani A., Palladino G., Napoletano R., Tenuta M., Masarone D., Limongelli G., Riccio E., Frustaci A., Chimenti C., Ferri C., Pieruzzi F., Pieroni M., Spada M., Castana C., Caserta M., Monte I., Rodolico M.S., Feriozzi S., Battaglia Y., Amico L., Losi M.A., Autore C., Lombardi M., Zoccali C., Testa A., Postorino M., Mignani R., Zachara E., Giordano A., Colomba P., Duro, G, Zizzo, C, Cammarata, G, Burlina, A, Polo, G, Scalia, S, Oliveri, R, Sciarrino, S, Francofonte, D, Alessandro, R, Pisani, A, Palladino, G, Napoletano, R, Tenuta, M, Masarone, D, Limongelli, G, Riccio, E, Frustaci, A, Chimenti, C, Ferri, C, Pieruzzi, F, Pieroni, M, Spada, M, Castana, C, Caserta, M, Monte, I, Rodolico, M, Feriozzi, S, Battaglia, Y, Amico, L, Losi, M, Autore, C, Lombardi, M, Zoccali, C, Testa, A, Postorino, M, Mignani, R, Zachara, E, Giordano, A, and Colomba, P
- Subjects
0301 basic medicine ,Proband ,Male ,Disease ,medicine.disease_cause ,Sphingolipid ,Catalysi ,lcsh:Chemistry ,0302 clinical medicine ,Gla gene ,Fabry disease ,GLA gene ,LysoGb3 ,Medicine ,Child ,lcsh:QH301-705.5 ,Spectroscopy ,chemistry.chemical_classification ,Genetics ,Allele ,Aged, 80 and over ,Mutation ,Computer Science Applications1707 Computer Vision and Pattern Recognition ,General Medicine ,Middle Aged ,Phenotype ,3. Good health ,Computer Science Applications ,Child, Preschool ,Female ,Human ,Adult ,Adolescent ,Genotype ,Glycolipid ,Catalysis ,Article ,Inorganic Chemistry ,03 medical and health sciences ,Young Adult ,otorhinolaryngologic diseases ,Humans ,Physical and Theoretical Chemistry ,Molecular Biology ,Gene ,Alleles ,Aged ,Sphingolipids ,business.industry ,Organic Chemistry ,Infant, Newborn ,Infant ,Biomarker ,gla gene ,lysogb3 ,adolescent ,adult ,aged ,aged, 80 and over ,alleles ,amino acid substitution ,biomarkers ,child ,child, preschool ,fabry disease ,female ,genotype ,glycolipids ,humans ,infant ,infant, newborn ,male ,middle aged ,phenotype ,sphingolipids ,young adult ,alpha-galactosidase ,mutation ,medicine.disease ,030104 developmental biology ,Enzyme ,chemistry ,lcsh:Biology (General) ,lcsh:QD1-999 ,Amino Acid Substitution ,alpha-Galactosidase ,Glycolipids ,business ,030217 neurology & neurosurgery ,Biomarkers - Abstract
Anderson-Fabry disease (FD) is a rare, progressive, multisystem storage disorder caused by the partial or total deficit of the lysosomal enzyme &alpha, galactosidase A (&alpha, Gal A). It is an X-linked, lysosomal enzymopathy due to mutations in the galactosidase alpha gene (GLA), encoding the &alpha, Gal A. To date, more than 900 mutations in this gene have been described. In our laboratories, the study of genetic and enzymatic alterations related to FD was performed in about 17,000 subjects with a symptomatology referable to this disorder. The accumulation of globotriaosylsphingosine (LysoGb3) was determined in blood of positives. Exonic mutations in the GLA gene were detected in 471 patients (207 Probands and 264 relatives): 71.6% of mutations were associated with the classic phenotype, 19.8% were associated with the late-onset phenotype, and 8.6% of genetic variants were of unknown significance (GVUS). The accumulation of LysoGb3 was found in all male patients with a mutation responsible for classic or late-onset FD. LysoGb3 levels were consistent with the type of mutations and the symptomatology of patients. &alpha, Gal A activity in these patients is absent or dramatically reduced. In recent years, confusion about the pathogenicity of some mutations led to an association between non-causative mutations and FD. Our study shows that the identification of FD patients is possible by associating clinical history, GLA gene analysis, &alpha, Gal A assay, and blood accumulation of LysoGB3. In our experience, LysoGB3 can be considered a reliable marker, which is very useful to confirm the diagnosis of Fabry disease.
- Published
- 2018
6. Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
- Author
-
Francesco Salvatore, Aurora Daniele, Luca Cegolon, Alessandro P. Burlina, Chiara Cazzorla, Giulia Polo, Andrea Celato, Alberto Burlina, Pamela Massa, Laura Giordano, Cazzorla, C, Cegolon, L, Burlina, Ap, Celato, A, Massa, P, Giordano, L, Polo, G, Daniele, Aurora, Salvatore, F, Burlina, Ab, Cazzorla, C., Cegolon, L., Burlina, A. P., Celato, A., Massa, P., Giordano, L., Polo, G., Daniele, A., Salvatore, F., Burlina, A. B., Scudiero, O, Nigro, E, Monaco, Ml, Oliviero, G, Polito, R, Borbone, N, D'Errico, S, Mayol, L, and Piccialli, G.
- Subjects
Quality of life ,Adult ,Male ,medicine.medical_specialty ,Pediatrics ,Adolescent ,Phenylketonurias ,Surveys and Questionnaires ,Epidemiology ,medicine ,Surveys and Questionnaire ,Phenylketonuria ,Humans ,Word health organization quality of life questionnaire-100 ,Amino Acids ,Child ,Tetrahydrobiopterin ,business.industry ,Dietary Protein ,Public Health, Environmental and Occupational Health ,medicine.disease ,Biopterin ,Diet ,Dietary Proteins ,Female ,Linear Models ,Patient Compliance ,Quality of Life ,Confidence interval ,humanities ,Regimen ,Amino Acid ,Mood disorders ,Cohort ,Linear Model ,Observational study ,business ,Research Article ,Human - Abstract
Background: Phenylketonuria (PKU) is a chronic inborn error of amino acid metabolism that requires lifelong follow-up and intervention, which may represent strains on Quality of Life (QoL). This observational study evaluated QoL in a cohort of PKU patients, using updated and detailed instruments. Methods: 22 patients with mild PKU respondent to BH4 and 21 patients with classical PKU treated with diet were recruited in this study. Adult patients completed WHOQOL questionnaire-100 (WHOQOL-100) and pediatric patients the Pediatric QoL inventory (PedsQL™). Psychiatric and mood disorders were also evaluated using TAD or BDI and STAI-Y inventories. A multivariable linear regression model was fitted to investigate the predictors of QoL, including age, sex, treatment type, length of current treatment, educational level and employment status (only for adults) as covariates. Results were presented as regression coefficients with 95% confidence interval. Results: Global QoL scores were within normal range both in patients with mild and classical disease but global QoL scores were significantly higher in patients with mild PKU under BH4 treatment as compared to those affected by classical disease who were under diet regimen. Furthermore, QoL significantly increased in long treated PKU patients. Among adult patients, QoL scores were significantly lower in males, in patients with lower education and in those employed or unemployed as compared to students (baseline). Conclusions: Both diet and medical treatment based upon BH4 seem to be associated with higher QoL in the long run. However, patients with mild PKU can rely on BH4 to achieve a higher Phe tolerance and a better compliance to therapy due to diet relaxation/avoidance. Some specific categories of patients with a lower QoL should be investigated more in depth, engaging with those at risk of lower treatment compliance. The questionnaires employed in the present study seemed to be able to effectively detect criticalities in QoL assessment and represent an advance from previous inventories employed in the past. A series of secondary diaryl and dialkyl nitrosamines have been synthesised and tested as substrates and/or inhibitors of highly purified acetyl-cholinesterase from Torpedo fuscomaculata. None were found to act as substrate, but many could selectively inhibit the enzyme. Kinetic analysis has shown that all the nitrosamines act as reversible competitive inhibitors with respect to the substrate, acetylthiocholine chloride; with time they act as irreversible covalent inhibitors. Scatchard analysis indicates that aliphatic nitrosamines have a weaker affinity for the enzyme compared to the aromatic and heterocyclic nitrosamines. In all cases the number of binding sites was four. Pseudo first-order kinetics are observed with the rate constant being proportional to the concentration of the nitrosamine and the order of reaction being equal to one. © 1994 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
- Published
- 2014
7. The hypoxic transcription factor KlMga2 mediates the response to oxidative stress and influences longevity in the yeast Kluyveromyces lactis
- Author
-
Ilaria Camponeschi, Germano Polo, Cristina Mazzoni, Teresa Rinaldi, Michele M. Bianchi, Alessio Immesi, Luca Brambilla, Rosa Santomartino, Santomartino, R, Camponeschi, I, Polo, G, Immesi, A, Rinaldi, T, Mazzoni, C, Brambilla, L, and Bianchi, M
- Subjects
ROS ,catalase ,fatty acids ,life span ,lipid droplets ,superoxide dismutase ,Transcription Factor ,lipid droplet ,Fungal Protein ,medicine.disease_cause ,Applied Microbiology and Biotechnology ,Microbiology ,Superoxide dismutase ,Fungal Proteins ,03 medical and health sciences ,Kluyveromyces ,Kluyveromyce ,Lipid droplet ,medicine ,Hypoxia ,Transcription factor ,Membrane Protein ,030304 developmental biology ,Kluyveromyces lactis ,0303 health sciences ,biology ,030306 microbiology ,Catabolism ,Membrane Proteins ,General Medicine ,Metabolism ,biology.organism_classification ,BIO/19 - MICROBIOLOGIA GENERALE ,Adaptation, Physiological ,CHIM/11 - CHIMICA E BIOTECNOLOGIA DELLE FERMENTAZIONI ,Cell biology ,Oxidative Stress ,Glucose ,Gene Expression Regulation ,biology.protein ,fatty acid ,Reactive Oxygen Species ,Reactive Oxygen Specie ,Oxidative stress ,Transcription Factors ,Signal Transduction - Abstract
Hypoxia is defined as the decline of oxygen availability, depending on environmental supply and cellular consumption rate. The decrease in O2 results in reduction of available energy in facultative aerobes. The response and/or adaptation to hypoxia and other changing environmental conditions can influence the properties and functions of membranes by modifying lipid composition. In the yeast Kluyveromyces lactis, the KlMga2 gene is a hypoxic regulatory factor for lipid biosynthesis—fatty acids and sterols—and is also involved in glucose signaling, glucose catabolism and is generally important for cellular fitness. In this work we show that, in addition to the above defects, the absence of the KlMGA2 gene caused increased resistance to oxidative stress and extended lifespan of the yeast, associated with increased expression levels of catalase and SOD genes. We propose that KlMga2 might also act as a mediator of the oxidative stress response/adaptation, thus revealing connections among hypoxia, glucose signaling, fatty acid biosynthesis and ROS metabolism in K. lactis.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.